The activation of the Notch4–Wnt–GDF15 axis in induced regulatory T (Treg cells) dampens their immunoregulatory function and turns them into TH2 and TH17 cytokine producers, allowing them to maintain ongoing allergic asthma.
References
Bailis, W. et al. Immunity 39, 148–159 (2013).
Harb, H. et al. Nat. Immunol. https://doi.org/10.1038/s41590-020-0777-3 (2020).
Amsen, D. et al. Cell 117, 515–526 (2004).
Tindemans, I. et al. J. Allergy Clin. Immunol. 140, 1079–1089 (2017).
Xia, M., Harb, H., Saffari, A., Sioutas, C. & Chatila, T. A. J. Allergy Clin. Immunol. 142, 1243–1256.e17 (2018).
Verhein, K. C. Environ. Health Perspect. 123, 799–805 (2015).
Geng, J. Nat. Immunol. 18, 800–812 (2017); erratum 18, 1270 (2017).
van Loosdregt, J. et al. Immunity 39, 298–310 (2013).
Yu, Q. et al. Nat. Immunol. 10, 992–999 (2009).
Rigas, D. J. Allergy Clin. Immunol. 139, 1468–1477.e2 (2017).
Verhamme, F. M. Mucosal Immunol. 10, 1400–1411 (2017).
Varelas, X. Dev. Cell 18, 579–591 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hammad, H., Lambrecht, B.N. Wnt and Hippo pathways in regulatory T cells: a NOTCH above in asthma. Nat Immunol 21, 1313–1314 (2020). https://doi.org/10.1038/s41590-020-0797-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0797-z
- Springer Nature America, Inc.
This article is cited by
-
Pathogenesis of allergic diseases and implications for therapeutic interventions
Signal Transduction and Targeted Therapy (2023)
-
GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing
Molecular and Cellular Biochemistry (2023)
-
Hippo signaling pathway and respiratory diseases
Cell Death Discovery (2022)
-
Notch signaling pathway: architecture, disease, and therapeutics
Signal Transduction and Targeted Therapy (2022)